Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluid biomarkers in multiple sclerosis: from current to future applications.
Di Filippo M, Gaetani L, Centonze D, Hegen H, Kuhle J, Teunissen CE, Tintoré M, Villar LM, Willemse EAJ, Zetterberg H, Parnetti L. Di Filippo M, et al. Among authors: villar lm. Lancet Reg Health Eur. 2024 Aug 22;44:101009. doi: 10.1016/j.lanepe.2024.101009. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444698 Free PMC article. Review.
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.
Domínguez-Mozo MI, Casanova I, Monreal E, Costa-Frossard L, Sainz-de-la-Maza S, Sainz-Amo R, Aladro-Benito Y, Lopez-Ruiz P, De-Torres L, Abellán S, Garcia-Martinez MA, De-la-Cuesta D, Lourido D, Torrado-Carvajal A, Gomez-Barbosa C, Linares-Villavicencio C, Villar LM, López-De-Silanes C, Arroyo R, Alvarez-Lafuente R. Domínguez-Mozo MI, et al. Among authors: villar lm. Int J Mol Sci. 2024 Sep 17;25(18):10012. doi: 10.3390/ijms251810012. Int J Mol Sci. 2024. PMID: 39337499 Free PMC article.
MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention.
Navarrete-Pérez A, Gómez-Melero S, Escribano BM, Galvao-Carmona A, Conde-Gavilán C, Peña-Toledo MÁ, Villarrubia N, Villar LM, Túnez I, Agüera-Morales E, Caballero-Villarraso J. Navarrete-Pérez A, et al. Among authors: villar lm. Int J Mol Sci. 2024 Sep 17;25(18):10009. doi: 10.3390/ijms251810009. Int J Mol Sci. 2024. PMID: 39337497 Free PMC article.
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.
Sainz de la Maza S, Rodero-Romero A, Monreal E, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Fernández-Velasco JI, Sainz-Amo R, Costa-Frossard L, Masjuan J, Villar LM. Sainz de la Maza S, et al. Among authors: villar lm. Front Immunol. 2024 Aug 22;15:1439393. doi: 10.3389/fimmu.2024.1439393. eCollection 2024. Front Immunol. 2024. PMID: 39238642 Free PMC article.
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.
Sainz-Amo R, Rodero Romero A, Monreal E, Chico García JL, Fernández Velasco JI, Villarrubia N, Veiga González JL, Sainz de la Maza S, Rodríguez Jorge F, Masjuan J, Costa-Frossard L, Villar LM. Sainz-Amo R, et al. Among authors: villar lm. Front Immunol. 2024 Aug 19;15:1454474. doi: 10.3389/fimmu.2024.1454474. eCollection 2024. Front Immunol. 2024. PMID: 39224593 Free PMC article.
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?
Saposnik G, Monreal E, Medrano N, García-Domínguez JM, Querol L, Meca-Lallana JE, Landete L, Salas E, Meca-Lallana V, García-Arcelay E, Agüera-Morales E, Martínez-Yélamos S, Gómez-Ballesteros R, Maurino J, Villar LM, Caminero AB. Saposnik G, et al. Among authors: villar lm. Mult Scler Relat Disord. 2024 Oct;90:105838. doi: 10.1016/j.msard.2024.105838. Epub 2024 Aug 23. Mult Scler Relat Disord. 2024. PMID: 39216454
425 results